Centers for Mendelian Genomics: A decade of facilitating gene discovery
- PMID: 35148959
- PMCID: PMC9119004
- DOI: 10.1016/j.gim.2021.12.005
Centers for Mendelian Genomics: A decade of facilitating gene discovery
Abstract
Purpose: Mendelian disease genomic research has undergone a massive transformation over the past decade. With increasing availability of exome and genome sequencing, the role of Mendelian research has expanded beyond data collection, sequencing, and analysis to worldwide data sharing and collaboration.
Methods: Over the past 10 years, the National Institutes of Health-supported Centers for Mendelian Genomics (CMGs) have played a major role in this research and clinical evolution.
Results: We highlight the cumulative gene discoveries facilitated by the program, biomedical research leveraged by the approach, and the larger impact on the research community. Beyond generating a list of gene-phenotype relationships and participating in widespread data sharing, the CMGs have created resources, tools, and training for the larger community to foster understanding of genes and genome variation. The CMGs have participated in a wide range of data sharing activities, including deposition of all eligible CMG data into the Analysis, Visualization, and Informatics Lab-space (AnVIL), sharing candidate genes through the Matchmaker Exchange and the CMG website, and sharing variants in Genotypes to Mendelian Phenotypes (Geno2MP) and VariantMatcher.
Conclusion: The work is far from complete; strengthening communication between research and clinical realms, continued development and sharing of knowledge and tools, and improving access to richly characterized data sets are all required to diagnose the remaining molecularly undiagnosed patients.
Keywords: Centers for Mendelian Genomics (CMG); Data sharing; Mendelian conditions; Novel gene-disease discovery; Rare disease tools.
Copyright © 2021 American College of Medical Genetics and Genomics. All rights reserved.
Conflict of interest statement
Conflict of Interest Baylor College of Medicine and Miraca Holdings Inc have formed a joint venture with shared ownership and governance of Baylor Genetics, formerly the Baylor Miraca Genetics Laboratories, which performs clinical ES and chromosomal microarray analysis for genome-wide detection of copy number variants. J.R.L. serves on the Scientific Advisory Board of Baylor Genetics. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, and is a coinventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. H.L.R. receives funding from Illumina to support rare disease gene discovery and diagnosis. Consortium author conflicts of interest are listed in the Supplement. All other authors have no disclosures relevant to the manuscript.
Figures


Similar articles
-
Insights into genetics, human biology and disease gleaned from family based genomic studies.Genet Med. 2019 Apr;21(4):798-812. doi: 10.1038/s41436-018-0408-7. Epub 2019 Jan 18. Genet Med. 2019. PMID: 30655598 Free PMC article. Review.
-
The Centers for Mendelian Genomics: a new large-scale initiative to identify the genes underlying rare Mendelian conditions.Am J Med Genet A. 2012 Jul;158A(7):1523-5. doi: 10.1002/ajmg.a.35470. Epub 2012 May 24. Am J Med Genet A. 2012. PMID: 22628075 Free PMC article.
-
Genomic Data Sharing for Novel Mendelian Disease Gene Discovery: The Matchmaker Exchange.Annu Rev Genomics Hum Genet. 2020 Aug 31;21:305-326. doi: 10.1146/annurev-genom-083118-014915. Epub 2020 Apr 27. Annu Rev Genomics Hum Genet. 2020. PMID: 32339034 Review.
-
The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities.Am J Hum Genet. 2015 Aug 6;97(2):199-215. doi: 10.1016/j.ajhg.2015.06.009. Epub 2015 Jul 9. Am J Hum Genet. 2015. PMID: 26166479 Free PMC article. Review.
-
PhenoDB, GeneMatcher and VariantMatcher, tools for analysis and sharing of sequence data.Orphanet J Rare Dis. 2021 Aug 18;16(1):365. doi: 10.1186/s13023-021-01916-z. Orphanet J Rare Dis. 2021. PMID: 34407837 Free PMC article.
Cited by
-
2022 Curt Stern Award: Advancing genomic medicine through collaboration and data sharing.Am J Hum Genet. 2023 Mar 2;110(3):410-413. doi: 10.1016/j.ajhg.2023.01.013. Am J Hum Genet. 2023. PMID: 36868203 Free PMC article.
-
Resources and tools for rare disease variant interpretation.Front Mol Biosci. 2023 May 10;10:1169109. doi: 10.3389/fmolb.2023.1169109. eCollection 2023. Front Mol Biosci. 2023. PMID: 37234922 Free PMC article. Review.
-
Pathogenic variants in TMEM184B cause a neurodevelopmental syndrome via alteration of metabolic signaling.medRxiv [Preprint]. 2024 Jul 1:2024.06.27.24309417. doi: 10.1101/2024.06.27.24309417. medRxiv. 2024. PMID: 39006436 Free PMC article. Preprint.
-
Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly.Genet Med. 2024 Nov;26(11):101218. doi: 10.1016/j.gim.2024.101218. Epub 2024 Jul 19. Genet Med. 2024. PMID: 39036895 Free PMC article.
-
The Role of Genetics in Advancing Cardiometabolic Drug Development.Curr Atheroscler Rep. 2024 May;26(5):153-162. doi: 10.1007/s11883-024-01195-6. Epub 2024 Mar 7. Curr Atheroscler Rep. 2024. PMID: 38451435 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
- UM1 HG008900/HG/NHGRI NIH HHS/United States
- UM1 HG006504/HG/NHGRI NIH HHS/United States
- K23 DK114551/DK/NIDDK NIH HHS/United States
- T32 HG010464/HG/NHGRI NIH HHS/United States
- UM1 HG006542/HG/NHGRI NIH HHS/United States
- R35 NS105078/NS/NINDS NIH HHS/United States
- K08 HG008986/HG/NHGRI NIH HHS/United States
- UM1 HG006493/HG/NHGRI NIH HHS/United States
- U24 HG008956/HG/NHGRI NIH HHS/United States
- U01 HG011758/HG/NHGRI NIH HHS/United States
- P50 HD103538/HD/NICHD NIH HHS/United States
- R01 HG009141/HG/NHGRI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous